Mechanism of Action for NNZ-2566 Anti-inflammatory Effects Following PBBI Involves Upregulation of Immunomodulator ATF3
@article{Cartagena2013MechanismOA, title={Mechanism of Action for NNZ-2566 Anti-inflammatory Effects Following PBBI Involves Upregulation of Immunomodulator ATF3}, author={C. Cartagena and K. L. Phillips and Garry L. Williams and Melissa Konopko and F. Tortella and J. Dave and Kara E. Schmid}, journal={NeuroMolecular Medicine}, year={2013}, volume={15}, pages={504-514} }
The tripeptide glycine–proline–glutamate analogue NNZ-2566 (Neuren Pharmaceuticals) demonstrates neuroprotective efficacy in models of traumatic brain injury. In penetrating ballistic-like brain injury (PBBI), it significantly decreases injury-induced upregulation of inflammatory cytokines including TNF-α, IFN-γ, and IL-6. However, the mechanism by which NNZ-2566 acts has yet to be determined. The activating transcription factor-3 (ATF3) is known to repress expression of these inflammatory… CONTINUE READING
Figures and Topics from this paper
19 Citations
The role for IGF-1-derived small neuropeptides as a therapeutic target for neurological disorders
- Medicine
- Expert opinion on therapeutic targets
- 2015
- 20
Neuroprotection with Glycine-2-Methylproline-Glutamate (G-2MePE) after hypoxic-ischemic brain injury in adult rats
- Medicine
- 2014
- PDF
Microglial Inflammasome Activation in Penetrating Ballistic-Like Brain Injury.
- Chemistry, Medicine
- Journal of neurotrauma
- 2018
- 33
Activating transcription factor 3, an early cellular adaptive responder in ischemia/reperfusion-induced injury
- Medicine
- Ci ji yi xue za zhi = Tzu-chi medical journal
- 2018
- 2
The role of microglial inflammasome activation in pyroptotic cell death following penetrating traumatic brain injury
- Medicine
- Journal of Neuroinflammation
- 2019
- 24
Treatment of traumatic brain injury with anti-inflammatory drugs
- Medicine
- Experimental Neurology
- 2016
- 69
Fragile X targeted pharmacotherapy: lessons learned and future directions
- Medicine
- Journal of Neurodevelopmental Disorders
- 2017
- 56
Retracted: Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566
- Biology, Medicine
- Genes, brain, and behavior
- 2017
- 6
References
SHOWING 1-10 OF 56 REFERENCES
NNZ-2566 treatment inhibits neuroinflammation and pro-inflammatory cytokine expression induced by experimental penetrating ballistic-like brain injury in rats
- Medicine
- Journal of Neuroinflammation
- 2009
- 62
NNZ-2566, a glypromate analog, improves functional recovery and attenuates apoptosis and inflammation in a rat model of penetrating ballistic-type brain injury.
- Medicine
- Journal of neurotrauma
- 2009
- 39
NNZ-2566: A Gly–Pro–Glu analogue with neuroprotective efficacy in a rat model of acute focal stroke
- Medicine
- Journal of the Neurological Sciences
- 2009
- 23
Neuroprotective effects of Gly-Pro-Glu, the N-terminal tripeptide of IGF-1, in the hippocampus in vitro.
- Biology, Medicine
- Neuroreport
- 1999
- 50
Negative Regulation of TLR-Signaling Pathways by Activating Transcription Factor-31
- Biology, Medicine
- The Journal of Immunology
- 2007
- 186
- PDF
Astrocytes produce and release interleukin-1, interleukin-6, tumor necrosis factor alpha and interferon-gamma following traumatic and metabolic injury.
- Medicine
- Journal of neurotrauma
- 2001
- 241
Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4
- Biology, Medicine
- Nature
- 2006
- 665
- PDF
Cortical injury increases cholesterol 24S hydroxylase (Cyp46) levels in the rat brain.
- Biology, Medicine
- Journal of neurotrauma
- 2008
- 44
Distinct cellular patterns of upregulated chemokine expression supporting a prominent inflammatory role in traumatic brain injury.
- Biology, Medicine
- Journal of neurotrauma
- 2008
- 134